Milan: positive day for Philogen
(Teleborsa) - The Developer of biopharmaceutical products for the treatment of life-threatening conditions puts in a decidedly bullish performance, gaining +3.45%.On a weekly basis, the stock is trending higher than the FTSE Italia Mid Cap. The performance of Philogen, in fact, has been higher than the related benchmark index.
According to the short-term technicals, Philogen will continue its positive development to test the resistance area of 21.17 Euros. There is the possibility of a decline to the 20.67 low. Overall, we expect the stock to breakout and test new resistance at 21.67.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 10-17-2024 12:30 PM